Daniel J. Wallace, MD

Associate Director, Fellowship Program, Rheumatology
Email:daniel.wallace@cshs.org
Phone:(310) 652-0920
Fax:(310) 360-4812

Awards and Activities

Healthcare Professional Leadership Award, Sjogren's Syndrome Foundation2012
Medical Achievement Award, SLE Foundation2011
Editor: The Sjogrens Book (Sjogrens Syndrome Foundation) 4th and 5th edition2007 - 2012
Author: The Lupus BookCurrent
Editor: Dubois Lupus Erythematosus 3rd-8th editions1985 - 2012
President, Research and Education Foundation of the American College of Rheumatology1994 - 2000
President, Lupus Foundation of America1999 - 2000
Founder and chairman of Scientific Advisory Board: Lupus LA2000
Medical Advisory Board: Lupus Research Institute2012

Research Focus

Systemic lupus erythematosus: genetic susceptibility, environmental risk, biomarkers, clinical trials, patient reported outcome measures, cardiac complilcations
Rheumatoid arthritis: environmental risk, clinical trials
Sjogren's syndrome: biomarkers, genetics, clinical trials

Research Contributions

Leader in the discovery of new autoantibodies, clinical trial design for autoimmune diseases, and has published significant insights into the mechanisms of actions of drugs used for these disorders and their environmental and genetic associations.

Current investigations include:

Collaborative efforts with several lupus and Sjogren's consortiums (e.g., SLICC) to evaluate biomarkers, genetic and environmental associations, outcomes and prognostic markers, disease activity indices. Involved in 40 different initiatives including 10 biologic agents in clinical trials. Recent grant to evaluate clinical optimization of autoantibody testing. Collaboration with Continuing Medical Education for quality improvement in lupus education.

Selected Publications

  1. Klinenberg JR, Wallace D: Plasmapheresis in Raynaud's disease. Lancet, 1(8077): 1310-1, 1978
  2. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL: Systemic lupus erythematosus--survival patterns. Experience with 609 patients. JAMA, 245(9): 934-8, 1981
  3. Wallace D, Goldfinger D, Lowe C, Nichols S, Weiner J, Brachman M, Klinenberg JR: A double-blind, controlled study of lymphoplasmapheresis versus sham apheresis in rheumatoid arthritis. N. Engl. J. Med., 306(23): 1406-10, 1982
  4. Wallace DJ, Margolin K, Waller P: Fibromyalgia and interleukin-2 therapy for malignancy. Ann. Intern. Med., 108(6): 909, 1988
  5. Wallace DJ: The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. Semin. Arthritis Rheum., 18(4): 282-96, 1989
  6. Chong PJ, Matzner WL, Wallace DJ, Klinenberg JR, Toyoda M, Jordan SC: 1,25 dihydroxyvitamin-D3 regulation of immunoglobulin production in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. J. Autoimmun., 2(6): 861-7, 1989
print button
WP1